BioSpace News Archive

Announces artificial intelligence implications of its Surgical SpotlightTM platform to drive operational profitability across health systems.

This year, joimax® is focusing on their Endoscopic Tower Generation 4 Devices, an expert solution for spinal surgery.

EMA Confirmed OMS721 Eligibility for European Centralized Marketing Authorization Application Review

During 1 to 30 November 2018, holders of warrants of series TO 1 B and TO 2 A of Diamyd Medical AB have been able to subscribe for shares through warrants. A total of 426 037 A shares and 12 409 855 B shares have been subscribed for, which means a subscription rate of 95.6 percent. Diamyd Medical thus raises approximately SEK 58.4 million before issue costs.

Results available now - third annual healthcare survey on payment collection challenges and technology adoption trends

Andreas Balsiger Betts joins along with Olivier Goarnisson to expand the firm’s capabilities and establish the first global life sciences practice serving all language areas of Switzerland

Company plans to become leading cannabis operator in Massachusetts, Michigan and Illinois markets

EmoCellix will focus on marketing a complete solution for hemostasis cytomolecular diagnostics

Global Cord Blood Corporation today announced the results of its 2018 Annual General Meeting, which was held on December 5, 2018, in Hong Kong S.A.R., China.